Silver nanoparticle-based drug delivery systems in the fight against COVID-19: enhancing efficacy, reducing toxicity and improving drug bioavailability-Reference-Cited by-同舟云学术

Silver nanoparticle-based drug delivery systems in the fight against COVID-19: enhancing efficacy, reducing toxicity and improving drug bioavailability

Published:2024-05-24 Issue:7 Volume:32 Page:794-806
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Yoosefian Mehdi¹,Sabaghian Hanieh¹

Affiliation:

1. Department of Chemistry, Graduate University of Advanced Technology, Kerman, Iran

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2024.2356147

Reference120 articles.

1. The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants

2. A suitable drug structure for interaction with SARS‐CoV‐2 main protease between boceprevir, masitinib and rupintrivir; a molecular dynamics study

3. Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives

4. Antiviral potential of nanoparticles for the treatment of Coronavirus infections

5. COVID-19 vaccines

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine;Pharmaceuticals;2024-08-12

2. Electronic and vibrational spectroscopic study complemented with the computational evaluation of hydroxychloroquine mixed with silver nanoparticles;Results in Chemistry;2024-08

3. Evaluating Molecular Mechanism of Viral Inhibition of Aerosolized Smart Nano-Enabled Antiviral Therapeutic (SNAT) on SARS-CoV-2-Infected Hamsters;Toxics;2024-07-05